236 related articles for article (PubMed ID: 26773728)
1. Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation.
Bo QL; Chen YH; Yu Z; Fu L; Zhou Y; Zhang GB; Wang H; Zhang ZH; Xu DX
Mol Cell Endocrinol; 2016 Mar; 423():51-9. PubMed ID: 26773728
[TBL] [Abstract][Full Text] [Related]
2. Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity.
Chen YH; Hu XG; Zhou Y; Yu Z; Fu L; Zhang GB; Bo QL; Wang H; Zhang C; Xu DX
J Immunol; 2016 Dec; 197(12):4762-4770. PubMed ID: 27821667
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit.
Chen YH; Yu Z; Fu L; Wang H; Chen X; Zhang C; Lv ZM; Xu DX
Sci Rep; 2015 Jun; 5():10871. PubMed ID: 26065916
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide Downregulates 11β-Hydroxysteroid Dehydrogenase 2 Expression through Inhibiting Peroxisome Proliferator-Activated Receptor-γ in Placental Trophoblasts.
Fu L; Chen YH; Bo QL; Song YP; Ma L; Wang B; Xu S; Zhang C; Wang H; Xu DX
J Immunol; 2019 Sep; 203(5):1198-1207. PubMed ID: 31315888
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N
Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368
[TBL] [Abstract][Full Text] [Related]
7. Folic acid protects against lipopolysaccharide-induced preterm delivery and intrauterine growth restriction through its anti-inflammatory effect in mice.
Zhao M; Chen YH; Dong XT; Zhou J; Chen X; Wang H; Wu SX; Xia MZ; Zhang C; Xu DX
PLoS One; 2013; 8(12):e82713. PubMed ID: 24324824
[TBL] [Abstract][Full Text] [Related]
8. Zinc supplementation during pregnancy protects against lipopolysaccharide-induced fetal growth restriction and demise through its anti-inflammatory effect.
Chen YH; Zhao M; Chen X; Zhang Y; Wang H; Huang YY; Wang Z; Zhang ZH; Zhang C; Xu DX
J Immunol; 2012 Jul; 189(1):454-63. PubMed ID: 22661087
[TBL] [Abstract][Full Text] [Related]
9. Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model.
Lee S; Kim W; Kang KP; Moon SO; Sung MJ; Kim DH; Kim HJ; Park SK
Nephrol Dial Transplant; 2005 Jun; 20(6):1057-65. PubMed ID: 15797891
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation during pregnancy protects against lipopolysaccharide-induced neural tube defects in mice.
Zhao M; Chen YH; Chen X; Dong XT; Zhou J; Wang H; Wu SX; Zhang C; Xu DX
Toxicol Lett; 2014 Jan; 224(2):201-8. PubMed ID: 24177262
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 pretreatment protects against lipopolysaccharide-induced early embryo loss through its anti-inflammatory effects.
Zhou Y; Chen YH; Fu L; Yu Z; Xia MZ; Hu XG; Wang H; Xu DX
Am J Reprod Immunol; 2017 Mar; 77(3):. PubMed ID: 28045211
[TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic acid protects against lipopolysaccharide-induced fetal growth restriction via inducing the ubiquitination and degradation of NF-κB p65 in placental trophoblasts.
Bo Q; Xie Y; Lin Q; Fu L; Hu C; Zhang Z; Meng Q; Xu F; Wang G; Miao Z; Wang H; Xu D
J Nutr Biochem; 2023 Aug; 118():109359. PubMed ID: 37085060
[TBL] [Abstract][Full Text] [Related]
14. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
[TBL] [Abstract][Full Text] [Related]
15. [The role of peroxisome proliferator-activated receptor-γ/nuclear factor-ΚB transduction pathway on coagulation disorders induced by sepsis].
Sun Y; Wang J; Yu L; Dai L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):520-4. PubMed ID: 26049195
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of rosiglitazone against acetaminophen-induced acute liver injury is associated with down-regulation of hepatic NADPH oxidases.
Wang JX; Zhang C; Fu L; Zhang DG; Wang BW; Zhang ZH; Chen YH; Lu Y; Chen X; Xu DX
Toxicol Lett; 2017 Jan; 265():38-46. PubMed ID: 27866976
[TBL] [Abstract][Full Text] [Related]
17. [Effect of nuclear factor-kappaB on peroxisome proliferator activated receptor gamma expression in Ana-1 cells].
Xiao B; Wang JC; Wang GS; Ji FY; Xu J
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):3-7. PubMed ID: 19141181
[TBL] [Abstract][Full Text] [Related]
18. Trans-10, cis-12 conjugated linoleic acid and the PPAR-γ agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-α production by bovine immune cells.
Perdomo MC; Santos JE; Badinga L
Domest Anim Endocrinol; 2011 Oct; 41(3):118-25. PubMed ID: 21798687
[TBL] [Abstract][Full Text] [Related]
19. Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain.
Xu DX; Wang H; Ning H; Zhao L; Chen YH
J Pineal Res; 2007 Aug; 43(1):74-9. PubMed ID: 17614838
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
